LS@W supports Life Sciences startups through the Venture Challenge, Expert Classes and Value Center programs. Startups that have participated in (one or more) of these programs are listed as LS@W alumni. In addition startups that have received an NGI Pre-Seed Grant, which was part of LS@W from 2007 - 2012, are listed as LS@W alumni.
The Venture Challenge is the most successful program for startups in the Life Sciences and Medical Technology. More than 25 editions of the Venture Challenge have been organised helping startups in Therapeutics, Diagnostics, Medical Devices and Enabling Technologies. Startups that have participated in the Venture Challenge and still exist are listed.
Pre-Seed Grant Alumni
In the first years of LifeSciences@Work the NGI Pre-Seed Grant was part of the program. Startups that have received a Pre-Seed Grant via the LS@W program and still exist are listed.
BIMINI Biotech is developing therapeutic strategies for major unmet medical needs. Our first development program targets the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing.
CC Diagnostics offers a superior, easily implementable triage test with an unsurpassed specificity and reproducibility, which will decrease the number of misdiagnosed women, decrease healthcare costs, and increase screening participation.
ciPTEC is a human renal cell line that mimics the proximal tubule cells of the kidney. These cells are a main target for drug-induced kidney injury, caused by their role in highly efficient transport of drugs and toxic compounds from the bloodstream into urine. The most relevant drug transporter proteins involved in this process are stably and functionally expressed in our cell models.
ClearDetections offers agricultural (inspection) laboratories a turn-key solution that could completely replace the current routine nematode detection through microscopic examination, enabling large-scale, sensitive and accurate monitoring of soil quality.